ArticleFrontiers in immunology2025

AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity.

Fan Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.